PIRPHYTO

Piramal Phytocare Limited has informed the Exchange that Dr. Vandana Sonavaria, Non-Executive, Non Independent Director of the Company has resigned with effect from February 21, 2017.

Piramal Phytocare Limited has informed the Exchange regarding Contact details of Key Managerial Personnel as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Piramal Phytocare Limited has informed the Exchange that the Board of Directors, at its meeting held on February 8, 2017 has Appointed Mr. Rajiv Salvi was appointed as the Manager of the Company for a period of 3 years with effect from February 08, 2017.

Piramal Phytocare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2016.

Piramal Phytocare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2016.

Piramal Phytocare Limited has informed the Exchange that Dr. Ashish Suthar, Manager and Key Managerial Personnel, has resigned from the services of the Company with effect from close of business hours of October 06, 2016. The Company is in the process of appointing a new Manager.

Piramal Phytocare Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on August 4, 2016.

Piramal Phytocare Limited has submitted to the Exchange a copy of voting results of Annual General Meeting of the Company held on August 04, 2016, along with a copy of Scrutinizer's Report.

Piramal Phytocare Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended June 30, 2016.

Piramal Phytocare Limited has informed the Exchange regarding Notice of Annual General Meeting as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Intimation of remote E- voting facility

Piramal Phytocare Limited has informed the Exchange the 15th Annual General Meeting of the Company is scheduled to be held on August 04, 2016.

Piramal Phytocare Limited has submitted to the Exchange the standalone financial results along with the Auditors Report for the period ended March 31, 2016.

Piramal Phytocare Limited has informed the Exchange that the 'Trading Window' for dealing in the securities of the Company will remain closed from May 7, 2016 to May 16, 2016 (both days inclusive) i.e. after 48 hours from the time the results are communicated to the Stock Exchange from the date of the meeting.

Ajay G Piramal has submitted to the Exchange vide letter dated May 2, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The Sri Krishna Trust has submitted to the Exchange, vide letter dated March 01, 2016 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Piramal Phytocare Limited has informed the Exchange about the Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 & Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201- Piramal Phytocare Limited Code for Fair Disclosure of Information & Determination of Materiality

The Sri Krishna Trust has submitted to the Exchange, vide letter dated February 15, 2016 a copy of disclosure under Regulation 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Piramal Phytocare Limited has informed the Exchange regarding the contact details of the Key Managerial Personnel of the Company, for determining materiality of an event or information and for making disclosures to the stock exchanges under Regulation 30.

Piramal Phytocare Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended December 31, 2015.

Piramal Phytocare Limited has informed the Exchange that the 'Trading Window' for dealing in the securities of the Company will remain closed from January 29, 2016 to February 6, 2016 (both days inclusive) i.e. after 48 hours from the time the results are communicated to the Stock Exchange from the date of the meeting.

Piramal Phytocare Limited has informed the Exchange that "We have noticed a sudden volatility in the Company's stock price over the last few days. During this period, neither the Company has made any announcement nor has there been any material development with regards to Company's operations. In line with our group's strong corporate governance framework, looking at the sudden stock price movement, we would like our investors to undertake careful evaluation before making any investment decision in the Company's stock".

Piramal Phytocare Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2015.

Piramal Phytocare Limited has informed the Exchange that the 'Trading Window' for dealing in the securities of the Company which has been closed from October 21, 2015, will now remain closed till November 2, 2015 i.e. after 48 hours from the time the results are communicated to the Stock Exchanges on the date of the Meeting.

Piramal Phytocare Limited has informed the Exchange that the 'Trading Window' for dealing in the securities of the Company is closed from October 21, 2015 to October 30, 2015 i.e. after 48 hours from the time the results are communicated to the Stock Exchanges on the date of the Meeting.

Piramal Phytocare Limited has informed the Exchange regarding Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 Company's Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.

Piramal Phytocare Limited has submitted to the Exchange a copy of voting results of Annual General Meeting of the Company held on August 12, 2015, pursuant to Clause 35A of the Listing Agreement.

Piramal Phytocare Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2015.

Piramal Phytocare Limited has informed the Exchange that the ' Trading Window" for dealing in the securities of the Company is closed from August 05, 2015 to August 14, 2015. i.e. after 48 hours from the time the results are communicated to the stock exchange on the date of the Meeting.

Piramal Phytocare Limited has informed the Exchange that Mr. Neelesh Bhise has resigned as the Company Secretary of the Company with effect from close of business hours of July 10, 2015 and Mr. Maneesh Sharma, a member of The Institute of Company Secretaries of India has been appointed as the Company Secretary of the Company with effect from July 22, 2015.

Piramal Phytocare Limited has informed the Exchange that the Annual General Meeting has been re-scheduled and will be held on August 12, 2015 instead of on July 24, 2015 as intimated earlier. Accordingly, the Register of Members and Share Transfer Books shall now remain closed from August 6, 2015 to August 12, 2015 (both days inclusive) for the purpose of Annual General Meeting of the Company instead of from July 17, 2015 to July 24, 2015.

Piramal Phytocare Limited has informed the Exchange that the Annual General Meeting of the Company has been re-scheduled and will be held on August 12, 2015, instead of on July 24, 2015.

Piramal Phytocare Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from July 17, 2015 to July 24, 2015 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on July 24, 2015.

Piramal Phytocare Limited has submitted to the exchange the standalone financial results for the period ended 31-Mar-2015.

Piramal Phytocare Limited has informed the Exchange that the Trading Window for dealing in the securities of the Company by the Directors/Officers / Designated Employees of the Company will remain closed from May 01, 2015 to May 09, 2015

Ajay G Piramal has submitted to the Exchange vide letter dated April 01, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Piramal Phytocare Limited has informed the Exchange that Mr. Karthik Muralidharan has been appointed as the Chief Financial Officer (CFO) of the Company with effect from April 01, 2015.

Piramal Phytocare Limited has informed the Exchange that the Board of Directors vide circular resolution dated March 24, 2015, have approved the appointment of Dr. Vandana Sonavaria as an Additional Director (Non-Executive) of the Company with effect from March 24, 2015.

Piramal Phytocare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 13, 2015,noted that Mr. Deepak Tipnis has tendered his resignation as the Chief Financial Officer (CFO) of the Company with effect from close of business hours on February 13, 2015. The Company is in the process of appointing a new CFO.

Piramal Phytocare Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 31-Dec-2014.

Piramal Phytocare Limited has informed the Exchange that the Trading Window for dealing in the securities of the Company by the Directors/Officers/ Designated Employees of the Company will remain closed from February 6, 2015 to February 14, 2015 pursuant to clause V of Code for Prevention of Insider Trading in Securities of the Company [framed by the Company in compliance with sub-regulation 12(1) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992].

Piramal Phytocare Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2014.

The Exchange sought clarification from Piramal Phytocare Limited with respect to news item captioned "Piramal to exit drug discovery business". The Company has clarified that "Piramal Phytocare Limited (formerly known as Piramal Life Sciences Limited) is not a subsidiary of Piramal Enterprises Limited as incorrectly mentioned in the captioned news article. The news article also inadvertently mentions that the business of drug discovery or new chemical and biological entity research is carried on by the Company. However, this business was demerged to Piramal Enterprises Limited during financial

The Sri Krishna Trust (through its Corporate Trustee- Piramal Management Services Private Limited) has submitted to the Exchange, vide letter dated August 06, 2014 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Piramal Phytocare Limited as submitted to the Exchange vide letter dated August 06, 2014 a copy of disclosure under Regulation 13(3), 13(4), 13(4A) & 13(6) of SEBI (Prohibition of Insider Trading) Regulations 1992.

Piramal Phytocare Limited as submitted to the Exchange vide letter dated August 06, 2014 a copy of disclosure under Regulation 13(3), 13(4), 13(4A) & 13(6) of SEBI (Prohibition of Insider Trading) Regulations 1992.

Piramal Phytocare Limited has submitted to the Exchange vide letter dated August 06, 2014 a copy of disclosure under Regulation 13(3), 13(4), 13(4A) & 13(6) of SEBI (Prohibition of Insider Trading) Regulations 1992.

The Sri Krishna Trust has submitted to the Exchange vide letter dated August 05, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The Sri Krishna Trust has submitted to the Exchange vide letter dated August 05, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Propiedades Realties Private Limited has submitted to the Exchange, vide letter dated August 05, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The Sri Krishna Trust has submitted to the Exchange, vide letter dated July 25, 2014 a copy of disclosure under Regulation 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.